Food-related symptoms, dietary interventions, and importance of the gut microenvironment in IBS

Abstract

Irritable bowel syndrome (IBS) is characterized by chronic gastrointestinal (GI) symptoms, including abdominal pain and altered bowel habits i.e., constipation and diarrhea. The pathophysiology is complex and multifactorial and many IBS patients report their symptoms to be associated with certain food items, including gluten and carbohydrates. Two of the most common dietary interventions in IBS are the gluten-free diet and a diet low in specific carbohydrates i.e., fermentable oligo-, di-, monosaccharides, and polyols (FODMAP). In this thesis, the overall aim was to assess if dietary interventions can improve GI symptoms through specific dietary and physiologic mechanisms in IBS. Study I assessed the daily intake of gluten and associations with GI symptoms in IBS. IBS patients ingested 11g of gluten per day, and patients with lower intake of gluten had more severe symptoms. It may be the case that IBS patients with severe symptoms attempt to alleviate their symptoms by reducing gluten intake. Study II compared the effects of gluten-free and gluten-containing diets in IBS and healthy individuals. The gluten-free diet did not improve GI symptoms compared with the gluten-containing diet and should not be recommended to all IBS patients. However, a subset of IBS patients improved on the gluten-free diet and metabolites produced by the gut microbiota may potentially predict the response to a gluten-free diet. Study III compared the effects of diets with low and moderate FODMAP content in IBS. The low FODMAP diet reduced GI symptoms compared with the moderate FODMAP diet, and a low FODMAP diet can be recommended to IBS patients. Both gluten-free and low FODMAP diet reduced the reports of loose stools, suggesting that dietary interventions could be more effective in non-constipated IBS. Study IV assessed associations between postprandial symptoms and several physiologic mechanisms in IBS, including transit time, rectal sensitivity, and hydrogen/methane production. Transit time, hydrogen/methane production, and (postprandial) GI symptoms are reciprocally associated, highlighting the importance of GI motility and the gut microenvironment in the pathophysiology of IBS. Measures of transit time could provide guidance on relevant treatments. In summary, this thesis provides insights on mechanisms and associations involved in food-related symptoms, on efficacy of dietary interventions, and the importance of the gut microenvironment in IBS.

Description

Keywords

Irritable bowel syndrome, Gastrointestinal symptoms, Gluten, FODMAP

Citation

ISBN

978-91-8069-825-2 (TRYCK)
978-91-8069-826-9 (PDF)

Articles

Algera JP, Störsrud S, Lindström A, Simrén M, Törnblom H. Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study. Clinical Nutrition 2021; 40(10): 5365-5372. http://doi.org/10.1016/j.clnu.2021.09.002

Algera JP, Magnusson MK, Öhman L, Störsrud S, Simrén M, Törnblom, H. Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2022; 56(9): 1318-1327. http://doi.org/10.1111/apt.17239

Algera JP, Demir D, Törnblom H, Nybacka S, Simrén M, Störsrud S. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: a randomized crossover trial. Clinical Nutrition 2022; 41(12): 2792-2800. http://doi.org/10.1016/j.clnu.2022.11.001

Algera JP, Colomier E, Melchior C, Hreinsson JP, Midenfjord I, Clevers E, Simrén M, Törnblom H. Associations between postprandial symptoms, hydrogen and methane production and transit time in irritable bowel syndrome. Neurogastroenterology and Motility 2023; 35(2): e14482. http://doi.org/10.1111/nmo.14482

Department

Institute of Medicine. Department of Molecular and Clinical Medicine

Defence location

Fredagen den 27 september 2024, kl. 9.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3, Göteborg

Endorsement

Review

Supplemented By

Referenced By